(BPMC) Blueprint Medicines complete technical analysis [charts+indicators] | Buy/Sell Blueprint Medicines | (BPMC) share price targets
Complete technical analysis of Blueprint Medicines (BPMC) by charts plus indicators, forecast predictions and share price targets for Blueprint Medicines (BPMC)
Blueprint Medicines trades in USA in Health Care sector.
Showing technical analysis as on 2025-02-12 View latest technical analysis
10 day averaged volume of Blueprint Medicines is 1037020
| Date | Daily Closing Price | Open | High | Low | Volume |
| 12 Wed Feb 2025 | 103.56 | 99.33 | 104.92 | 99.08 | 1.107 times |
| 11 Tue Feb 2025 | 101.57 | 103.01 | 104.09 | 100.72 | 0.941 times |
| 10 Mon Feb 2025 | 104.00 | 105.15 | 105.15 | 100.76 | 1.775 times |
| 07 Fri Feb 2025 | 104.98 | 109.43 | 110.55 | 103.98 | 1.205 times |
| 06 Thu Feb 2025 | 109.62 | 110.37 | 112.00 | 108.84 | 0.926 times |
| 05 Wed Feb 2025 | 110.37 | 113.55 | 115.77 | 110.17 | 1.127 times |
| 04 Tue Feb 2025 | 113.40 | 110.61 | 114.14 | 110.61 | 0.855 times |
| 03 Mon Feb 2025 | 111.50 | 109.20 | 112.70 | 109.06 | 0.73 times |
| 31 Fri Jan 2025 | 112.53 | 114.49 | 116.23 | 112.18 | 0.558 times |
| 30 Thu Jan 2025 | 114.05 | 115.00 | 116.00 | 112.73 | 1.253 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 106, but if it comes above 106, then a intra day buy could be more profitable.
If you take a sell trade below 106, then use 106 as stoploss and 101 as target. However if you take a buy trade in stock , then use 106 as stoploss and 110.29 as target.
Share price targets for Blueprint Medicines (BPMC)
| Target Type | Value |
| Downside Target | 80.68 |
| Downside Target | 85.91 |
| Downside Target | 94.98 |
| Downside Target | 98.41 |
| Downside Target | 103.55 |
| Upside Target | 108.16 |
| Upside Target | 110.28 |
| Upside Target | 112.18 |
| Upside Target | 115.77 |
| Upside Target | 117.48 |
| Upside Target | 118.25 |
Intraday share price targets for Blueprint Medicines (BPMC)
| Target Type | Value |
| Downside Intraday Target | 100.04 |
| Downside Intraday Target | 96.53 |
| Upside Intraday Target | 106.11 |
| Upside Intraday Target | 108.67 |
| Downside Intraday Target | 102.6 |
Weekly technical analysis of Blueprint Medicines (BPMC)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 12 Wed Feb 2025 | 103.56 | 105.15 | 105.15 | 99.08 | 0.789 times |
| 07 Fri Feb 2025 | 104.98 | 109.20 | 115.77 | 103.98 | 1.327 times |
| 31 Fri Jan 2025 | 112.53 | 113.90 | 118.25 | 112.18 | 1.027 times |
| 24 Fri Jan 2025 | 114.91 | 110.24 | 117.48 | 108.16 | 3.792 times |
| 17 Fri Jan 2025 | 110.05 | 105.87 | 110.28 | 104.73 | 0.15 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Blueprint Medicines (BPMC)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 12 Wed Feb 2025 | 103.56 | 109.20 | 115.77 | 99.08 | 0.444 times |
| 31 Fri Jan 2025 | 112.53 | 88.06 | 118.25 | 86.72 | 1.977 times |
| 31 Tue Dec 2024 | 87.22 | 96.29 | 98.41 | 85.91 | 0.829 times |
| 26 Tue Nov 2024 | 94.63 | 87.53 | 103.55 | 87.28 | 0.85 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Blueprint Medicines (BPMC)
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Blueprint Medicines stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Blueprint Medicines in short term but the sell signal is initial and weak.
Blueprint Medicines Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Blueprint Medicines in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Blueprint Medicines is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 107.98 and Blueprint Medicines (BPMC) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Blueprint Medicines stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Blueprint Medicines in short term but the sell signal is initial and weak.
Blueprint Medicines Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Blueprint Medicines in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Blueprint Medicines is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 107.98 and Blueprint Medicines (BPMC) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.